Determination of sensitivity and specificity of a novel gene dosage assay for prenatal screening of trisomy 21 syndrome. - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles Clinical Biochemistry Year : 2012

Determination of sensitivity and specificity of a novel gene dosage assay for prenatal screening of trisomy 21 syndrome.

Abstract

OBJECTIVE: To compare the gene dosage results achieved by a novel multiplex quantitative assay with cytogenetic and quantitative fluorescent polymerase chain reaction (QF-PCR) analysis for prenatal screening of trisomy 21 syndrome on corresponding fetal samples. DESIGN AND METHODS: Fetal samples (n=134) were collected from pregnant women considered high risk for having trisomy 21 affected fetus. Cytogenetic analysis and QF-PCR were performed. Then, the relative gene dosage of DSCAM and DYRK1A2 genes was determined on corresponding samples using comparative delta cycle of threshold (ΔC(T)) method. RESULTS: The mean gene dosage ratio was 1.55 ± 0.11 (95% CI:1.51-1.58) in trisomy 21 cases and 1.01 ± 0.12 (95% CI:0.98-1.03) in normal samples (p value<0.001). The results were in agreement to the results of cytogenetic and QF-PCR analysis with the overall specificity of 0.96 (95% CI:0.91-0.98) and the sensitivity of 0.80 (95% CI:0.49-0.94). CONCLUSIONS: This gene dosage assay is appropriate for the screening of high risk pregnant women and is readily amenable to automation.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

pasteur-00759565 , version 1 (01-12-2012)

Identifiers

Cite

Ahmad Reza Kamyab, Fahimeh Shahrokhi, Elmira Shamsian, Mina Hayat Nosaied, Parvin Dibajnia, et al.. Determination of sensitivity and specificity of a novel gene dosage assay for prenatal screening of trisomy 21 syndrome.. Clinical Biochemistry, 2012, 45 (3), pp.267-71. ⟨10.1016/j.clinbiochem.2011.11.013⟩. ⟨pasteur-00759565⟩

Collections

RIIP RIIP_IRAN
44 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More